2 results
Approved WMOCompleted
Primary Objective During Double-Blind Period:To compare the efficacy of BMS-945429 SC versus placebo on a background of methotrexate as assessed by ACR20 response rates at 12 weeks.Secondary Objectives During Double-Blind Period:1) To assess…
Approved WMOCompleted
Primary Objective:to clinically use and validate the optimized Raman probe in a patient database in order to differentiate between benign and malignant bladder lesions in vivo.Secondary objective:to develop an algorithm to predict tumor grade in…